Sotio
0 followers
‌
Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Industries
+1
Headquarters
Employees
Links
Org chart
Radek Å pÃÅ¡ek
Collapse
Pavel Solský
Chief Financial & Commercial Officer
Geoffrey Hodge
CEO, Sotio US
Martin Steegmaier
Chief Scientific Officer
Daniela Červená
Chief Accountant
Gaëtan Decherf
CFO At Sotio Biotech AG
Robyn Hunter
Chief Financial Officer
Lorraine Whittemore
Regulatory Affairs And Quality Assurance, Vice President
Dana Tomaszewski
Vice President Information Technology
